Single protect against dangerous
Lung Cancer ~ Lung Cancer ~ Breast Cancer ~ Heart attack
Home / Health News / 2008 / March 2008 / March 20, 2008
Single jab may protect against dangerous tick diseases

Top News

Karnataka High Court orders Ramoji Rao to appear in Ballari Court

CCEA approves scheme on National Mission on Medicinal Plants

Magnets could keep sharks at bay!

Pammie was first choice for X-Files lead role!

Chidambaran says government to speed up reforms

ICC chief Haroon Lorgat to meet the media in Colombo

Bossy parents cause older teens to indulge in more sex

Aussies turning in droves to alternative therapies

Single jab may protect against dangerous tick diseases

Researchers at the Centers for Disease Control and Prevention in Fort Collins, Colorado, USA, have developed an injection that protects against two severe diseases transmitted by tick bites: Lyme disease and Anaplasmosis.

Washington, Mar 20 : Researchers at the Centers for Disease Control and Prevention in Fort Collins, Colorado, USA, have developed an injection that protects against two severe diseases transmitted by tick bites: Lyme disease and Anaplasmosis.

In 2006, the US saw nearly 20,000 cases of Lyme disease and there are up to 2,000 cases a year in the UK, a figure that is increasing steadily.

However, now researchers have said that it might get cured with a single injection.

"Along the North-eastern seaboard of the US, ticks are often co-infected with the bacteria that cause Lyme disease and Anaplasmosis," said Dr Nordin Zeidner.

"Currently there is no vaccine to protect against either organism. We have shown that a single injection of sustained-release antibiotics can prevent both diseases in mice," Zeidner added.

During the study, the researchers found that a single dose of doxycycline given orally is only 20-30 percent effective at preventing these diseases in mice.

However, a new formulation of doxycycline hyclate that is programmed to release the drug over a 20-day period is 100 percent effective.

"The underlying copolymer formulation has been in use for over 20 years. It has no adverse effect on humans and it can be programmed to release a drug over several weeks to several months," Zeidner said.

"We plan to test the doxycycline formulation to develop different release kinetics and delivery methods. For example, a slow release patch could be used in conjunction with current recommended protection against ticks, such as repellents and personal tick checks," Zeidner added.

The study is published in the Journal of Medical Microbiology.

ANI

July 24, 2008

July 23, 2008

July 22, 2008

July 21, 2008

July 20, 2008

July 19, 2008